Company profile

Syndeio Biosciences

Enhancing synaptic health in patients with CNS disorders

Industry
Biotechnology Research
Employees
22
Headquarters
Indianapolis, IN
Founded
2025
LinkedIn followers
1,466
Office locations
2

Syndeio Biosciences company summary

Syndeio Biosciences is a company in the Biotechnology Research industry, headquartered in Indianapolis, IN, founded in 2025. On LinkedIn the company has around 22 employees and 1,466 followers. The company lists 2 office locations.

What technology does Syndeio Biosciences use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Syndeio Biosciences

Syndeio Biosciences (from the Ancient Greek word “to connect”) is a clinical-stage biotechnology company developing therapies to restore and enhance synaptic health in CNS disorders. The company’s proprietary Boost™ Synapse Pharmacology Platform combines electrophysiology, behavior, and human neuronal network assays to predict clinical outcomes with unprecedented accuracy. Syndeio’s clinical pipeline includes lead asset, zelquistinel, currently in Phase 2 development for major depressive disorder and will soon be entering an industry-first biomarker study in Alzheimer’s disease, and apimostinel, currently in an investigator-led phase 2 study for acute depression. The company is headquartered in Indianapolis, IN with research laboratories in Menlo Park, CA & Evanston, IL focused on advancing the Boost™ Synapse Pharmacology Platform.

Where is Syndeio Biosciences located?

Syndeio Biosciences lists 2 office locations.

Indianapolis, IN, USHQ
Menlo Park, CA, US

Compare companies similar to Syndeio Biosciences

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
Syndeio Biosciences
syndeio.bio
Biotechnology Research222025Indianapolis, IN
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about Syndeio Biosciences

What does Syndeio Biosciences do?

Syndeio Biosciences (from the Ancient Greek word “to connect”) is a clinical-stage biotechnology company developing therapies to restore and enhance synaptic health in CNS disorders. The company’s proprietary Boost™ Synapse Pharmacology Platform combines electrophysiology, behavior, and human neuronal network assays to predict clinical outcomes with unprecedented accuracy. Syndeio’s clinical pipeline includes lead asset, zelquistinel, currently in Phase 2 development for major depressive disorder and will soon be entering an industry-first biomarker study in Alzheimer’s disease, and apimostinel, currently in an investigator-led phase 2 study for acute depression. The company is headquartered in Indianapolis, IN with research laboratories in Menlo Park, CA & Evanston, IL focused on advancing the Boost™ Synapse Pharmacology Platform.

How many employees does Syndeio Biosciences have?

Syndeio Biosciences has around 22 employees on LinkedIn.

Where is Syndeio Biosciences headquartered?

Syndeio Biosciences is headquartered in Indianapolis, IN.

Where does Syndeio Biosciences have offices?

Syndeio Biosciences lists 2 office locations, including Indianapolis, IN, US; Menlo Park, CA, US.

When was Syndeio Biosciences founded?

Syndeio Biosciences was founded in 2025.

Build a lead list from companies like Syndeio Biosciences

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.